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Several recent  studies  have  detailed the  phenomenon  of  synergy among  certain 
populations of parental  strain  lymphoid cells in  the  elicitation of  graft-versus-host 
(GVH) 1 reactions in neonatal F1 mice  (1-5).  When  either a  spleen  weight  assay in 
normal recipients or a  mortality assay in sublethally irradiated recipients to quanti- 
tate the intensity of the GVH reaction was used, mixtures of either peripheral blood 
leukocytes (PBL) or femoral lymph node cells (LN) and either thymocytes or spleen 
cells from  donors pretreated with  a  moderate  dose of  heterologous antithymocyte 
serum  (ATS)  regularly gave reactions significantly greater  than  expected by  sum- 
ming the reactivities of the components of the mixture measured separately. 
These  results  suggested that  optimal expression of  GVH  reactions may  require 
the  participation of  at  least  two  subpopulations of  donor  lymphoid cells.  Studies 
utilizing either  cells from  neonatally thymectomized  donors  (3)  or  cells incubated 
in vitro with anti-0 serum and complement (5)  indicated that both of these subpopu- 
lations  were  thymus-derived  cells,  thereby  clearly  distinguishing  this  synergistic 
reaction from  those seen among certain  thymus-derived and  bone  marrow-derived 
cells in  the  production  of  humoral  antibodies  to  a  variety of  antigens  (6-9).  In 
addition, both cell types had  to  have  the capacity to  recognize foreign antigens in 
the  FI recipients; no  synergy was  observed when  appropriate populations of  syn- 
geneic F1 cells were substituted for either of the populations of parental strain lymph- 
oid cells (1-4),  again distinguishing this particular synergy from  that  described by 
others in GVH reactions in irradiated recipients (10-12). 
A  simple  two-cell model predicts that  the  intrinsic GVH  reactivity of any 
* This work was presented in part at the 56th Annual Meeting of the Federation of Ameri- 
can Societies for Experimental Biology, Atlantic City, N. J., April 1972. 
1 Abbreviations used in this paper: ATS, rabbit anti-mouse-thymocyte serum; BSA, bovine 
serum albumin; F1, C57BL/6N X BALB/cAnN F1; FCS, fetal calf serum; GVH, graft-versus- 
host; HBSS, Hanks' balanced salt solution; LN, lymph node cells; LNS, lymph node-seeking 
spleen cells; NLN, normal lymph node cells; NSp, normal spleen cells; PBL, peripheral blood 
leukocytes; SpS, spleen-seeking spleen cells. 
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given  lymphoid  tissue  is  the  result,  at  least  in  part,  of  an  interaction  among 
different  cell types.  The  present  experiments  were undertaken  to  see whether 
the existence of subpopulations  within a  single lymphoid tissue could be demon- 
strated  more  explicitly.  The  distribution  of  synergizing  populations  among 
different  lymphoid  "compartments"  and  their  relative  susceptibilities  to 
heterologous ATS in vivo (3)  both suggested  that  the relevant cell types might 
have  sufficiently different  migratory  patterns  and/or  rates  of  recirculation  to 
be  of  use  in  trying  to  achieve  their  separation.  The  results  reported  in  this 
paper  indicate  that  within a  normal  spleen  there  exist at least two  subpopula- 
tions  of  thymus-derived  cells  with  different  migratory  patterns  in  lethally 
irradiated  syngeneic  recipients.  Both  are  necessary  for  the  recovery  of  the 
GVH  reactivity characteristic  of this  tissue. 
Materials  and Methods 
Animals.--7-9-wk  old  male  BALB/cAnN,  C3H/HeN,  AKR/N,  and  C57BL/6N  X 
BALB/cAnN F1 mice and neonatal  (1-3-day old)  litters of C57BL/6N  X  BALB/cAnN F1 
were mice obtained from the Rodent and Rabbit Production Section, Divlsion of Research 
Services, National Institutes of Health, Bethesda, Md. 
Irradiation.--2  h before receiving the inoculation of syngeneic spleen cells,  mice were ex- 
posed to 800 R whole body irradiation. A Westinghouse (Westinghouse Electric Corporation, 
Baltimore, Md.)  Quadrocondex 250 kVp machine was used under conditions of 200 kVp,  15 
mA, half-value layer 0.9 mnr Cu, at a distance of 54 cm, and an administered dose rate of 139 
R/min. 
Cell Suspensions.--Groups  of animals were killed by cervical dislocation.  Suspensions  of 
spleen cells  and  lymph node cells  (pools  of inguinal,  axillary,  cervical, and  submandibular 
nodes only; mesenteric lymph nodes were excluded)  were prepared by mincing with scalpels 
and  repeated  gentle  pipetting  through  disposahle  Pasteur  pipettes,  followed by  filtration 
through gauze to remove dehris and cell clumps. All suspensions  were prepared and washed 
once  in  Hanks'  balanced  salt  solution  (HBSS;  Grand  Island  Biological  Co.,  Grand 
Island, N. Y.) containing 5~ heat-inactivated fetal calf serum (FCS, immunoprecipitin tested; 
Grand Island Biological Co.). Suspensions  were adjusted to the desired concentrations of total 
nucleated cells;  when mixtures of cells were used,  appropriate  concentrations  of each were 
mixed together immediately before inoculation. 
In  Vitro  Treatment  with  Anti-O  Ascitic  Fluid  and  Complement.--Anti-O  antibodies  were 
raised  by a  modification of the technique described by Reif and  Allen (13).  AKR/N mice 
received six weekly intraperitoneal injections of 107 C3H/HeN thymocytes. 4 days after the 
sixth injection, the mice were given 107 Ehrlich ascites tumor cells (generously provided by 
Dr. Kenneth Sell, National Naval Medical Center, Bethesda, Md.) intraperitoneally and 107 
C3H/HeN thymocytes suhcutaneously.  7 days later the ascitic fluid (anti-0)  was  collected, 
centrifuged to remove cells, heat inactivated at 56°C for 30 rain, and frozen at  --20°C until 
use. 
Anti-0 absorbed with brain tissue served as a control for specificity. BALB/cAnN or AKR/ 
N  brain was homogenized in a TenBroeck homogenizer and then washed several times with 
large volumes of HBSS. Anti-0 was then absorbed with packed brain tissue (3 : i vol/vol) for 30 
min at room temperature, with gentle shaking every 5 min to resuspend the tissue, centrifuged, 
and stored at --20°C until use. 
The anti-0 used in this study killed 50% of a suspension  of 106 BALB/c thymocytes at a 
dilution of 1:250 (dye exclusion  method). Anti-0 absorbed with BALB/c brain was not cyto- ROBERT  E.  TIGELAAR  AND  RICHARD ASOFSKY  241 
toxic at a dilution of i :5. Anti-0 absorbed with AKR brain killed 50% of BALB/c thymocytes 
at a dilution of 1:220. 
Cells to be treated were resuspended in RPMI 1640 (Grand Island Biological Co.) contain- 
ing 1% bovine serum albumin (BSA, Path-o-cyte 5; Miles Laboratories, Elkhart,  Ind.)  to a 
concentration of 100 M 106/ml. Tubes containing 0.5 ml of this suspension and 0.3 ml of either 
unabsorbed or absorbed anti-0 were incubated at 4°C for 30 rain. The cells were then washed 
once in 10 ml RPMI 1640 and resuspended to 0.5 ml. To this was added 1.0 ml of a  1:3 dilution 
of guinea pig complement (BBL Division, Becton-Dickinson & Co.,  Cockeysville,  Md.) that 
had previously been absorbed for 1 h at 4°C  with BALB/c spleen cells (1 spleen eq/ml diluted 
complement). After incubation at 37°C  for 45  rain,  the suspensions were washed twice in 
HBSS -/- 5% FCS and resuspended in the same diluent to the desired concentration of nu- 
cleated cells. 
GVII Assay.--The Simonsen quantitative spleen weight assay (14) was performed as de- 
scribed by Mandel and Asofsky (15). Briefly, litters of 1-3-day old C57BL/6N  M BALB/cAnN 
F1 mice were inoculated intraperitoneally with 0.05 ml of cell suspension. Two or three mice in 
each litter served as uninjected controls. Whenever combinations of cells were injected, other 
litters were also inoculated with the relevant populations alone as internal controls. 9 days later 
the litters were sacrificed,  and the resultant splenomegaly was quantitated as follows: spleen 
index =  (spleen weight to body weight ratio of experimental mouse)  +  (mean spleen weight to 
body weight ratio of uninjected littermate controls). Regression lines of spleen index as a func- 
tion of the logarithm of the cell inocula were calculated by the method of least squares. The 
slopes of these reactivity lines and individual data points were compared by means of a t test. 
Experimental Design.--The  basic model employed throughout these experiments is illus- 
trated in Fig. 1. 100 million normal adult spleen cells (either BALB/c or C57BL/6 X BALB/c 
F1 donors) were injected intravenously into syngeneic adult recipients that had received 800 R 
whole body irradiation 2 h previously. These mice were sacrificed  24 h later, and single cell 
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Fro. 1.  Experimental design. Spleen cells from normal adult mice were always injected into 
adult syngeneic irradiated recipients (either BALB/e or C57BL/6 X  BALB/e F1). Mesenteric 
lymph nodes were excluded from the pools of LNS. 2 Various numbers of LNS and/or SpS were 
then injected into neonatal C57BL/6 X BALB/c F1 litters and the GVH splenomegaly  quanti- 
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suspensions were made of either the pooled spleens or the lymph nodes (excluding mesenteric 
nodes). 2 These populations have been operationally defined as either "spleen-seeking spleen 
cells" (SpS) or "lymph node-seeking spleen cells" (LNS). Various numbers of these cells either 
alone or in combination were then injected into neonatal F1 recipients as described above. 
RESULTS 
Comparison  of Normal and Irradiated  Unreconstituted  Tissues.--Pretiminary 
studies  were  designed  to examine  the  cell  yields from the  spleens  and  lymph 
nodes of adult mice 24 h  after lethal  irradiation  and  to test  the  specific GVH 
reactivity  of  such  cells.  In  three  separate  experiments  the  average  yield  of 
nucleated  cells from irradiated  BALB/c mice was about 8  X  106 cells/spleen 
and approximately 1.5  X  l0 s cells/lymph node pool. These numbers represent 
about 15 %  of the cells recoverable from normal untreated donors, a 
The  reactivities  of normal  BALB/c  spleen  cells  and  lymph  node  cells  (in- 
dividual  data  points not shown)  are illustrated  in Fig.  23 As few  as 4  X  105 
LN or 8.5 X  l0  s spleen cells were sufficient to produce significant splenomegaly 
(in our hands,  a  spleen index greater than  1.3; see also reference  14)  in F1 re- 
cipients.  Injection of as many as  1.6  X  106 LN or 8  M  106 spleen  cells from 
donors given 800 R  24 h previously in no case resulted in spleen indices greater 
than  1.3.  Since large numbers of these cells were inactive,  any contribution of 
residual  host  cells  to  the  directly  measured  GVH  reactivity  of  tissues  from 
irradiated  reconstituted mice would be negligible. 
Reactivities  of  SpS  and  LXS  Alone.--The  spleens  of  lethally  irradiated 
BALB/c mice 24 h  after  injection  of 100  X  106 normal  BALB/c spleen  cells 
contained  approximately  22  X  106  nucleated  cells/spleen,  i.e.,  about  three 
times  the  number  recovered  from  unreconstituted  animals  (see  above).  The 
directly measured GVH reactivity of various numbers of these SpS is illustrated 
in  Fig.  2.  Each  point  represents  the  mean  spleen  index  (=l=l SEM)  of  5-15 
litters  (total number of litters  =  45). 
It is clear that SpS were less active than normal spleen cells by two criteria. 
More  SpS  than  normal  spleen  cells  were  required  to produce  a  minimal  sig- 
nificant spleen index of 1.3, approximately 3.0 X  106 SpS vs. 8.5 X  l0  s normal 
spleen cells.  Secondly, the regression line for SpS was significantly flatter than 
that for normal spleen  cells,  that is,  many more SpS than normal spleen cells 
were  required  to  produce  a  given  increment  in  the  observed  splenomegaly. 
The calculated  slopes of the  regression  lines were  1.75  for normal spleen  cells 
and 0.90 for SpS  (P  <  0.001). 
Suspensions of lymph node cells from irradiated mice injected 24 h previously 
with  100  X  106  normal  adult  spleen  cells  contained  approximately  4  X  106 
2 Tigelaar, R., and R. Asofsky. 1972. Synergy among lymphoid cells mediating the graft- 
versus host response. VI. Comparison of the amplifying activities of spleen,  inguinal lymph 
node, and mesenteric lymph node cells on the GVH reactivity  of thymocytes. Manuscript  in 
preparation. 
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nucleated cells/animal,  again about three times as many as recovered from the 
lymph  nodes  of  irradiated  unreconstituted  donors.  The  directly  measured 
GVH reactivity of these LNS is shown in Fig. 3; each point represents the mean 
spleen  index  (4-1  SEM)  of  three  to  eight  recipient  litters  (total  number  of 
litters  =  39).  In  a  comparison  with  the  population  from  which  they  were 
derived,  normal  spleen  cells,  it is clear that LNS,  like  SpS,  show a  strikingly 
fiat  dose-response  line.  The  slope  of  the  LNS  regression  line  was  0.55  and 
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FIG. 2.  GVH  reactivity  of BALB/c SpS  alone. Spleen indices are  plotted  against  the 
logarithm of the number of cells injected. Each point (O) represents the mean  spleen index 
(4-1 SEM) of 5-15 litters. Regression lines calculated by the method of least squares. Shown 
for reference (dotted lines) are the regression lines (data points not shown) for normal BALB/c 
ymph node (NLN) and normal BALB/c spleen NSp) cells. ~ 
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FIe. 3.  GVH reactivity of BALB/c LNS alone. Each point (0) represents the mean spleen 
index (4-1 SEM)  of 3  8 recipient  litters.  Regression line calculated by the method  of least 
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differed significantly from both  that of normal  spleen cells  (P  <  0.001)  and 
that of SpS  (P  <  0.005).  Thus the in vivo passage of normal spleen cells into 
irradiated  syngeneic  recipients  resulted  in  the  recovery  of  two  populations 
each of which had a significantly impaired capacity to initiate  GVH reactions 
in neonatal F1 recipients. 
It was considered that the extreme flatness of the lines of the LNS and SpS 
populations might be due to some sort of nonspecific suppressive activity exerted 
or released  by dying or residual  radioresistant  host  cells.  Three different ex- 
periments failed  to provide any evidence for such  a  suppressor activity.  (a) 
Normal spleen cells were incubated in vitro for 2 h  at room temperature with 
an equal number of spleen cells from donors irradiated  24 h  previously. The 
dose-response  curve  of  this  mixture  was  identical  with  that  obtained  with 
the  same numbers  of normal  spleen  cells  alone.  (b) Before  injection  into  F~ 
recipients, a suspension of SpS was layered on top of a two-step discontinuous 
BSA  gradient  (10%  top layer, 35%  cushion).  Tubes were centrifuged in  the 
cold at  10,000  rpm for 30 rain.  As  Bianco and  Nussenzweig  (16)  also noted, 
the pellet  (below 35%  BSA)  contained  the  majority of the  erythrocytes and 
nonviable  leukocytes,  while  the  layer above  the  35%  BSA  was  enriched  in 
viable  nucleated  cells.  The  dose-response  line  for  these  viable  cells  was  as 
shallow  as  that  seen  with  unfractionated  SpS  (Fig.  2).  (c)Normal  spleen 
ceils were injected into mice irradiated 24 h (instead of the usual 2 h) previously, 
and 24 h  later the GVH activity of the SpS population was tested. The dose- 
response line of these cells was again identical with that illustrated  in Fig.  2. 
Reactivity  of Mixtures of LNS and SpS.--Having  established the regression 
lines  for LNS  and  SpS  tested  separately,  we  then  performed experiments in 
which  these  two subpopulations of normal  spleen cells were  recombined in  a 
constant  but  arbitrary ratio  of  1:5  immediately before injection  into  F1  re- 
cipients. The results of these experiments are summarized in Fig. 4. The data 
points refer to the mean spleen indices (4-1  SEM)  seenin recipients inoculated 
with 2.0 X  106, 4.0 X  106, or 6.0 X  106 SpS each combined with one-fifth that 
number of LNS  (i.e.,  4.0  X  105, 8.0  X  105, and  1.2  X  l06,  respectively). For 
convenience  the  points  have  been  plotted  according  to  the  number  of  SpS 
in the inoculum. Each point represents data pooled from four to nine separate 
experiments and is the mean of 8-25 recipient litters (total number of litters = 
44). 
The striking return of the calculated regression line to a slope (2.23)  similar 
to that observed with normal spleen ceils (0.1  >  P  >  0.05) by combining two 
subpopulations each with very shallow dose-response lines is obvious. The slope 
of the regression line of the combination differs significantly (P <  0.001) from 
that seen with either LNS or SpS alone.  Had no synergy occurred within  the 
mixture  of LNS  and  SpS,  the  dose-response line  of the  mixture would  have 
been expected to be flat like those of the populations from which  the combi- 
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FIG. 4.  GVH reactivity of mixtures of BALB/c LNS and SpS. The data refer to the mean 
spleen index (4-1 SEM) of 2.0,4.0, or 6.0 X 106 SpS each combined  with one-fifth  that number 
of LNS. For convenience  the points have been plotted according to the number of SpS in the 
inoculum. Each point represents data pooled from 4-9 separate experiments (8-25 recipient 
litters per point). Regression  line calculated by the method of least squares. 
Since the slopes of the LNS and SpS regression lines are significantly different 
from each other, it is difficult to calculate accurate expected (i.e.  assuming no 
synergy)  spleen  indices  for the  combinations. Nevertheless,  a  rough estimate 
of such expected additive reactivity can be made. The combination of 8.0  X 
105 LNS +  4.0 X  106 SpS can serve as an example. By referring to the standard 
reactivity lines for LNS and SpS alone, one can see that the reactivity of 8.0 
X  105 LNS alone is equivalent to that seen with about 3.5  X  106 SpS alone. 
Additive  reactivity by the  mixture  would  be expected  to  be  that  shown  by 
about 7.5  X  106 SpS alone (3.5  X  10  ° +  4.0 X  106) or, reading from the SpS 
line, a spleen index of about 1.70. The observed reactivity of this combination, 
however, was 2.02  4- 0.05,  a  spleen index expected from nearly 20 X  106 SpS 
tested alone. Thus the observed reactivity of this particular combination was 
more than twice that expected by addition. 
In spite of the observation that both lymph node and spleen cells from donors 
lethally irradiated  but not  reconstituted  with syngeneic spleen cells were un- 
able to initiate  significant splenomegaly in  F1 recipients when tested directly, 
the possibility remained that the synergistic reactions seen in combinations of 
LNS and SpS in fact involved these residual, perhaps radioresistant, host cells. 
Under certain conditions  thymus-derived helper cell activity in humoral anti- 
body responses has been remarkably radioresistant  (17,  18).  In order to  test 
this  possibility,  4.0  X  106  SpS  were  combined  immediately before injection 
into  ]?'1 recipients  with  8.0  X  105  lymph  node  cells  from  irradiated  unre- 
constituted  donors.  The  reciprocal  combination  was  injected  into  other  F1 
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unreconstituted  donors.  In neither case  was there any evidence of synergistic 
reactivity. The reactions were similar to those seen with the reconstituted pop- 
ulation alone; the cells from irradiated unreconstituted donors neither enhanced 
nor depressed the reactivity of the active population in the mixture. 
Specificity  of the Reaction.--Previous  studies  (1-4)  had  shown  that  synergy 
was no longer observed if F1 cells were substituted for either of the populations 
of parental strain cells in  a  synergistic combination of thymocytes and  PBL, 
indicating that both populations had to have the capacity to recognize foreign 
antigens in the F1 recipient. It was of interest to test if the same were true in 
the present model. 
Irradiated  adult  Ft  mice  were  injected  with  100  X  106  normal  adult  F1 
spleen cells, and 24 h  later suspensions of lymph nodes and spleens were pre- 
pared.  At  the  same  time,  similar suspensions  were  prepared  from  irradiated 
BALB/c mice injected 24 h  before with normal BALB/c spleen cells. Various 
numbers of mixtures of LNS and SpS in a ratio of 1:5 were again injected into 
neonatal F1 recipients, except that now one of the populations in the mixture 
consisted of cells syngeneic to the F1 recipient. 
The results are illustrated in Fig. 5. Each point represents data pooled from 
two experiments and is the mean spleen index  (4-1  SEM)  of a  minimunl  of six 
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FI6.5. Failure of mixtures  of BALB/c and FI LNS and  SpS to restore the steep dose- 
response relationship shown by BALB/c NSp or mixtures of BALB/e LNS +  SpS. Upper half: 
4.0 X 105, 8.0 X 10 '~, or 1.2 X 106 BAI,B/c LNS each combined with five times that number 
Of F1 Spa. Regression line shown is that for BALB/c LNS tested alone (Fig. 3). Lower half: 
2.0, 4.0, or 6.0  X  106 BALB/c SpS each combined with one-fifth that number  of F1 LNS. 
Regression line shown is that for BALB/c SpS tested  alone (Fig. 2). Each data point is the 
mean spleen index (4-1 SEM) of six recipient litters. ROBERT  E.  TIGELAAR  AND  RICHARD  ASOFSKY  247 
recipient litters. The upper half of Fig. 5 shows the results obtained when 4.0 X 
10  5, 8.0 X  10  6, or 1.2 X  10 8 BALB/c LNS were inoculated together with five 
times those respective numbers of F1 SpS. The observed reactions did not differ 
significantly (P >  0.3)  from the reactions obtained when BALB/c LNS were 
injected alone (solid line, Fig. 3). The reciprocal experiments are illustrated in 
the lower half of Fig. 5, that is, 2.0 X  10  6, 4.0 X  10  6, or 6.0 X  10  6 BALB/c 
SpS inoculated together with one-fifth those respective numbers of F1 LNS. 
Again the observed reactions did not differ significantly (P  >  0.3)  from the 
reactions obtained with the respective numbers of BALB/c SpS  alone  (solid 
line, Fig. 2). Mixtures of F1 cells after migration and BALB/c cells after migra- 
tion displayed the reactivity expected from the BALB/c cells alone. There was 
no indication of such combinations' having the steep dose-response relationship 
exhibited either by normal BALB/c spleen cells  or by mixtures of  BALB/c 
LNS and SpS. 
Sensitivity  of Mixtures  of BALB/c  LNS  and  SpS  to  Anti-O  Treatment.- 
Having established that appropriate mixtures of BALB/c LNS and SpS gave a 
synergistic GVH reaction with dose-response  characteristics similar to those 
of the normal population from which they were derived, we thought it important 
to test whether the cell types responsible for this synergy were both thymus- 
derived, as had been found in a  previous model  (3,  5).  Accordingly, suspen- 
sions of LNS and SpS were each incubated in vitro with either unabsorbed or 
brain-absorbed anti-0 and complement. After incubation, various mixtures of 
treated and untreated cells were injected into litters of F1 recipients. 
The results of these experiments are summarized in Table I. Treatment of 
either one of the subpopulations with unabsorbed anti-0 completely eliminated 
the  synergistic reaction  observed  with untreated  mixtures.  Mixtures  of un- 
treated  LNS  and  anti-0-treated  SpS  exhibited  reactivity  not  significantly 
TABLE  I 
GVH Reactivity  of Synergistic  Mixtures of LNS and  SpS after In  Vitro  Incubation  with 
Anti-O  Ascitlc Fluid and  Complement 
#  LNS 
8 X  l0  s 
8 X  10  5 
8 X  10  5 
8 X  10  5 
8 X  lO  s 
In vitro 
treatment 
None 
Abs. anti~ + 
C~ 
None 
None 
Anti-0 -}- C 
SpS 
4  X  10  6 
4  X  10  6 
4 X 106 
4 X 106 
4 X 106 
In vitro 
treatment 
None 
Abs. anti-O 
C 
Antl-0 +  C 
None 
None 
it- 
ers 
Mean spleen 
index4- 1 
SEM 
2.02  ±  0.05 
1.95  4-  0.09 
1.34  4-  0.04 
1.49  4-  0.08 
1.41  4-  0.03 
1.48  4-  0.04 
Significance 
P  >  0.4  a  /p  <  0,001 d 
_P>0.1 b 
2°>0.1 c 
P  <  0.001 ° 
* Number of nucleated cells injected into FI recipients after in vitro incubation. 
2~ Absorbed with homogenate of BALB/c brain, 
a Group 1 compared with group 2; bgroup 3 compared with group 4; egroup 5 compared with group 6; dgroup 1 com- 
pared with group 4; egroup 1 compared with group 6. Student's t test used  throughout. 248  MIGRATION  OF  GVH-REACTIVE  SPLEEN  CELLS 
higher than that seen with untreated LNS alone (P >  0.1).  Similarly, mixtures 
of untreated SpS and anti-0-treated LNS exhibited reactivity not significantly 
higher than that seen with untreated SpS alone (P  >  0.1). Furthermore, ab- 
sorption of the anti-0 with BALB/c brain tissue, which is known to contain large 
amounts of the appropriate 0 isoantigen (13), completely removed the inhibitory 
activity from the ascitic fluid, whereas anti-0 absorbed with AKR/N brain (data 
not shown) produced an effect identical with that of unabsorbed anti-0. The 
activity of the anti-0, therefore, appeared to be due to antibodies reactive with 
thymus-derived cell antigens, not to antibodies of other specificities  that may 
be present in such a preparation (19-22). 
DISCUSSION 
It is well established that cell populations from different lymphoid tissues 
have  been  heterogeneous,  but  characteristic,  migratory  patterns  (23-28). 
Lance and Taub  (27, 28)  have shown that reproducible percentages of 5tCr- 
labeled  lymph  node  lymphocytes injected  into  either  normal  or  irradiated 
syngeneic recipients can be found 24 h later in both the lymph nodes and spleen. 
If these populations are  then inoculated in  a  secondary syngeneic recipient, 
the  original lymph node-seeking cells  "home" in  even greater proportion  to 
lymph nodes, as do the spleen cells to the secondary host's spleen. These migra- 
tory patterns most probably do not reflect an absolute tendency for a  given 
cell type to localize in a specific organ, but rather, relative recirculatory rates; 
that is, at any given time there is a greater probability of recovering cells be- 
longing to the rapidly recirculating pool from lymph nodes than from spleen. 
As Lance and Taub (27) point out, the mechanism(s) governing the specificity 
of "homing" is unknown; such characteristics as specific membrane structures 
and/or  affinity for postcapillary venular  endothelium in  lymph  nodes  (23) 
may well be involved. 
In spite  of our relative ignorance of the specific  mechanism involved,  the 
phenomenon of homing in syngeneic recipients provides a useful tool for study- 
ing lymphocyte heterogeneity. The  most common application  has  been  the 
direct  assessment  of  the  distributional  characteristics  of  different lymphoid 
populations,  i.e.,  the  definition of populations according  to  their  migratory 
patterns (27, 28). A second and to date less frequently used approach employs 
migration as a means of fractionating a population of lymphoid cells in order 
subsequently to test the resultant subpopulations for their relative functional 
activities. 
Lance and Taub  (27) reported that lymph node-seeking thymocytes, when 
compared  with  the  original  thymocyte suspension,  appeared  to  have  an  in- 
creased  capacity,  on  a  cell  for cell  basis,  to  cause graft-versus-host  disease. 
Cantor  (29)  found that the capacity to amplify an  antihapten antibody re- 
sponse in adoptive hosts was significantly greater, on a  cell for cell basis, for 
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primed spleen cell population. Stobo and Paul (30) have very recently shown 
that lymph node-seeking spleen cells  differ from normal  spleen cells  in their 
relative capacities to be stimulated in vitro by the mitogens phytohemaggluti- 
nin and concanavalin A. 
Studies of the  phenomenon of synergy among certain  populations  of pa- 
rental strain lymphoid cells  in the production of GVH reactions  (1-5)  have 
yielded data consistent with the idea that optimal expression of such reactions 
may involve some  sort  of interaction  between  at  least  two  thymus-derived 
cells.  One cell  is present in high concentrations in tissues rich in rapidly re- 
circulating lymphocytes, such as peripheral blood and lymph nodes; such cells 
demonstrate a high degree of sensitivity to in vivo treatment with heterologous 
ATS.  A  second  population  appears  to  be  relatively more  sessile,  since  it is 
found in higher concentrations in  such  tissues  as  spleen  and  thymus; these 
cells appear to be relatively more resistant to the effects of ATS. These differ- 
ences in distribution and ATS  sensitivity are compatible with the idea that 
the relevant populations might have different migratory patterns in syngeneic 
recipients. 
The migration model employed in these studies offered an  opportunity to 
test the hypothesis, on the basis of a simple two-cell model, that the intrinsic 
GVH reactivity of a  normal  lymphoid tissue  is  the  result,  at  least in part, 
of  an  interaction  among  subpopulations  with  different migratory patterns. 
The results reported here are consistent with this hypothesis. The lymph node- 
seeking and spleen-seeking subpopulations of normal spleen cells when tested 
alone each displayed impaired GVH reactivities compared with the reactivity 
of the population from which they were derived; each of the subpopulations 
had dose-response lines significantly flatter than those seen with normal spleen 
cells (or with any normal lymphoid tissue previously tested [1-3, 5]).2 Appropri- 
ate mixtures of the two subpopulations (in this case a  constant but arbitrary 
ratio of 1 part LNS  to 5  parts  SpS),  however,  completely and dramatically 
restored  the slope of the resultant reactivity line to a  slope  characteristic of 
the normal parent population. Clearly the reactivity of the mixtures was not 
explained by simple addition of the reactivities of the components of the mix- 
ture measured separately; such additive reactivity should have resulted in a 
dose-response line with a slope intermediate between those observed with either 
LNS or SpS alone. 
This  synergistic reactivity was  not  explained  by  the  contribution,  either 
immunologically specific or nonspecific, of the residual, perhaps radioresistant, 
host cells known to comprise approximately one-third of the cells in suspensions 
of either LNS or SpS. Furthermore, the experiments utilizing combinations of 
LNS and SpS in which either one of the populations consisted of cells syngeneic 
to the neonatal FI recipients indicated that in this model, as in the ones pre- 
viously described  (1-4),  both populations in a  mixture had to  have  the  ca- 
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be observed. Finally, if either of the LNS or SpS populations in a potentially 
synergistic mixture was treated in vitro with anti-0 and complement, no evi- 
dence  of synergy was subsequently  observed. This inhibitory capacity of the 
anti-0 was completely removed by prior absorption with an appropriate mouse 
brain  homogenate.  Thus  in  both  of  these  subpoputations,  the  relevant  cell 
type(s)  that was responsible for the  observed synergistic GVH reactions was 
thymus-derived. 
The finding of very flat dose-response lines for either LNS or SpS when tested 
alone is compatible with a  two-cell model in which  each of these populations 
has been relatively depleted  of one of the  thymus-derived cells necessary for 
full expression of GVH reactivity. Mixtures of the two populations would then 
result in a more optimal ratio of the two cell types, with the resultant steepen- 
ing of the observed dose-response line. Such steepening of the cell dose-response 
line in the antibody response to sheep erythrocytes has been observed in inter- 
actions  among  thymocytes  and  bone  marrow  cells  (31)  and  in  interactions 
among glass-adherent and nonadherent cells (32). 
On  the other hand,  both the marked flatness of the dose-response lines for 
LNS and SpS tested separately and the finding that these lines were definitely 
not  parallel  to  each  other  were  not  really  anticipated.  All  previous  studies 
testing  the  separately measured  reactivities of normal  lymphoid cell popula- 
tions such as PBL and  thymocytes had resulted in parallel and much steeper 
dose-response  lines,  even  though  appropriate  mixtures  of  these  suspensions 
gave reactions consistent with the idea that each of them had a relative excess 
of  a  complementary  thymus-derived  cell  subpopulation.  The  shallow  dose- 
response lines observed with LNS or SpS alone might be at least partially the 
result of "suppressor" cells derived from the donor inoculum (32-37). No such 
suppressive  activity  was  demonstrated  in  cell  populations  derived  from  ir- 
radiated  unreconstituted  mice.  The  possibility  that  irradiated  hosts  release 
suppressive humoral (serum) factors must also be considered. This seems rather 
unlikely in view of the striking synergy observed when the LNS and SpS sub- 
populations were recombined. 
The relationships between the subpopulations derived in the present model 
and  those utilized in previous studies  (1-5)  remain to be elucidated.  It is,  of 
course, tempting to speculate that LNS are the equivalent of normal PBL or 
LN and that SpS are the equivalent of normal thymocytes or spleen cells from 
ATS-treated donors. 
Previous studies of synergy in GVH reactions employed the basic design of 
first establishing parallel dose-response lines for various normal lymphoid tissues 
and  then demonstrating the superadditive reactivity of appropriate mixtures. 
This could  not  be  explained  adequately  by a  single-cell  model  in  which  the 
difference  in  reactivities  among  normal  tissues  was  simply  a  reflection  of 
differences  in  the  concentrations  of  this  active  cell.  The  results  suggested  a ROBERT  E.  TIGELAAR AND  RICHARD  ASOFSKY  251 
more complex model in which the normal  tissues were functionally heteroge- 
neous. 
The present  experiments have provided  a  more explicit demonstration  of 
such functional heterogeneity within the pool of thymus-derived cells present 
in a single normal lymphoid tissue. These subpopulations have different migra- 
tory patterns and/or rates of recirculation in irradiated syngeneic hosts. Either 
subpopulation by itself appears markedly deficient in its ability to provoke a 
GVH reaction, but appropriate mixtures of the two restore the reactivity line 
to a  slope characteristic of the normal population from which the subpopula- 
tions  were  derived.  These results  offer compelling evidence that the normal 
expression of GVH reactivity of a  given normal lymphoid tissue involves an 
interaction among distinct subpopulations of thymus-derived cells. 
SUMMARY 
Spleen cells from normal  adult mice were injected into lethally irradiated 
adult syngeneic recipients. 24 h later, cell suspensions were prepared from the 
recipients' spleens or peripheral lymph nodes and tested either alone or com- 
bined for their capacity to elicit graft-versus-host  (GVH) reactions in neonatal 
F1 recipients, using the Simonsen spleen weight assay. 
Either  the  lymph  node-seeking  subpopulation  or  the  spleen-seeking  sub- 
population alone was markedly deficient in its ability to provide a  GVH re- 
action when compared with the normal population from which it was derived. 
However, an  appropriate  mixture of the  two had  a  reactivity characteristic 
of the parent population. Both subpopulations were sensitive to treatment with 
anti-0 antibody and complement in vitro. 
These  results  provide  a  convincing demonstration  of  the  functional  het- 
erogeneity within the pool of thymus-derived cells present in a  single normal 
lymphoid tissue.  They strongly suggest  that  the  normal  expression of GVH 
reactivity of such a  tissue involves an interaction among distinct subpopula- 
tions of thymus-derived cells. 
We are indebted to Dr. Kenneth Sell, National Naval Medical Center, Bethesda, Md., for 
suggesting the method employed  in the present study for producing anti-0 antibody in quan- 
tity. 
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